Literature DB >> 627736

Repeated gonorrhea: an analysis of importance and risk factors.

G F Brooks, W W Darrow, J A Day.   

Abstract

This study was designed to assess the epidemiological importance of repeated infections due to Neisseria gonorrhoeae and to analyze variables potentially associated with repeated gonorrhea. The retrospective analysis was of 7,347 patients seen during one year, and the prospective study was of a stratified randomly selected sample of 429 patients. The 492 retrospectively identified repeaters constituted 0.06% of the county population and 6.7% of the clinic population. The 492 repeaters had 21.6% of the cases of gonorrhea reported from the county and 29.4% of the cases reported from the clinic. The repeaters tended to be younger than those without repeated infection (P less than 0.001), male (62%), black (81.7%), and residents of areas of lower socioeconomic status than those who were not repeaters (P less than 0.001). Most repeaters (73.5%) had not graduated from high school. Repeaters did not have significantly greater numbers of sex partners (P greater than 0.05) or greater exposure to prostitutes or clients than those who did not have repeated infections and less frequently had sexual contact while symptomatic. Intensive follow-up of the small number of high-risk repeaters and their contacts could result in a major reduction in the number of reported cases of gonorrhea.

Entities:  

Mesh:

Year:  1978        PMID: 627736     DOI: 10.1093/infdis/137.2.161

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Do the factors associated with successful contact tracing of patients with gonorrhoea and Chlamydia differ?

Authors:  J D Ross; A Sukthankar; K W Radcliffe; J Andre
Journal:  Sex Transm Infect       Date:  1999-04       Impact factor: 3.519

2.  Risk factors for gonorrhoea: case-control study.

Authors:  M Bjekić; H Vlajinac; S Sipetić; J Marinković
Journal:  Genitourin Med       Date:  1997-12

3.  Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.

Authors:  W Kern; S L Kennedy; M Sachdeva; E R Sande; D Gunderson; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

4.  Heterogeneities in the transmission of infectious agents: implications for the design of control programs.

Authors:  M E Woolhouse; C Dye; J F Etard; T Smith; J D Charlwood; G P Garnett; P Hagan; J L Hii; P D Ndhlovu; R J Quinnell; C H Watts; S K Chandiwana; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

5.  Relationship of the interval between infections and the similarity of gonococcal strains in recurrent gonorrhoea.

Authors:  R C Noble; A P Oranje; M F Michel; E Stolz
Journal:  Br J Vener Dis       Date:  1980-02

6.  Auxotypes and antimicrobial susceptibilities of Neisseria gonorrhoeae in black and white patients.

Authors:  R C Noble; B R Miller
Journal:  Br J Vener Dis       Date:  1980-02

7.  A method for identifying persons at high risk for sexually transmitted infections: opportunity for targeting intervention.

Authors:  C A Richert; T A Peterman; A A Zaidi; R L Ransom; J E Wroten; J J Witte
Journal:  Am J Public Health       Date:  1993-04       Impact factor: 9.308

8.  Local and humoral immune responses against primary and repeat Neisseria gonorrhoeae genital tract infections of 17beta-estradiol-treated mice.

Authors:  Wenxia Song; Sara Condron; Brian T Mocca; Sandra J Veit; Dawn Hill; Asima Abbas; Ann E Jerse
Journal:  Vaccine       Date:  2008-08-30       Impact factor: 3.641

9.  Quantitative culture of endocervical Chlamydia trachomatis.

Authors:  R C Barnes; B P Katz; R T Rolfs; B Batteiger; V Caine; R B Jones
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

10.  Risk profiles for genital infection in women.

Authors:  B A Evans; T Tasker; K D MacRae
Journal:  Genitourin Med       Date:  1993-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.